InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.950
+0.020 (0.68%)
Apr 23, 2025, 4:00 PM EDT - Market closed
InMed Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.42 | 6.57 | 8.91 | 6.18 | 7.36 | 5.81 | Upgrade
|
| Short-Term Investments | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | Upgrade
|
| Cash & Short-Term Investments | 3.46 | 6.61 | 8.96 | 6.22 | 7.41 | 5.85 | Upgrade
|
| Cash Growth | -63.88% | -26.15% | 43.96% | -16.03% | 26.70% | -67.48% | Upgrade
|
| Accounts Receivable | 0.26 | 0.35 | 0.26 | 0.09 | - | - | Upgrade
|
| Other Receivables | - | - | - | - | 0.01 | 0.05 | Upgrade
|
| Receivables | 0.26 | 0.35 | 0.26 | 0.09 | 0.01 | 0.05 | Upgrade
|
| Inventory | 1.1 | 1.24 | 1.62 | 2.49 | - | - | Upgrade
|
| Prepaid Expenses | 0.64 | 0.48 | 0.5 | 0.8 | 0.84 | 0.13 | Upgrade
|
| Other Current Assets | - | - | - | - | 0.11 | 0.29 | Upgrade
|
| Total Current Assets | 5.47 | 8.69 | 11.33 | 9.6 | 8.38 | 6.31 | Upgrade
|
| Property, Plant & Equipment | 1.23 | 1.25 | 0.72 | 0.9 | 0.33 | 0.4 | Upgrade
|
| Other Intangible Assets | 1.7 | 1.78 | 1.95 | 2.11 | 1.06 | 1.09 | Upgrade
|
| Other Long-Term Assets | 0.1 | 0.1 | 0.1 | 0.18 | 0.01 | - | Upgrade
|
| Total Assets | 8.5 | 11.82 | 14.11 | 12.79 | 9.78 | 7.8 | Upgrade
|
| Accounts Payable | 0.57 | 0.63 | 0.54 | 1.17 | 0.78 | 0.71 | Upgrade
|
| Accrued Expenses | 0.78 | 0.99 | 1.06 | 1.25 | 1.36 | 0.9 | Upgrade
|
| Current Portion of Leases | 0.42 | 0.32 | 0.38 | 0.4 | 0.08 | 0.07 | Upgrade
|
| Other Current Liabilities | 0.01 | 0.04 | 0.02 | 0.5 | - | - | Upgrade
|
| Total Current Liabilities | 1.79 | 1.97 | 2 | 3.32 | 2.22 | 1.68 | Upgrade
|
| Long-Term Leases | 0.53 | 0.64 | 0.02 | 0.39 | 0.19 | 0.25 | Upgrade
|
| Total Liabilities | 2.32 | 2.62 | 2.02 | 3.71 | 2.4 | 1.92 | Upgrade
|
| Common Stock | 84.54 | 82.78 | 77.62 | 70.72 | 60.59 | 53.07 | Upgrade
|
| Additional Paid-In Capital | 34.84 | 35.37 | 35.74 | 31.68 | 21.51 | 17.76 | Upgrade
|
| Retained Earnings | -113.33 | -109.08 | -101.4 | -93.45 | -74.85 | -64.65 | Upgrade
|
| Comprehensive Income & Other | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | -0.3 | Upgrade
|
| Shareholders' Equity | 6.18 | 9.21 | 12.09 | 9.08 | 7.38 | 5.88 | Upgrade
|
| Total Liabilities & Equity | 8.5 | 11.82 | 14.11 | 12.79 | 9.78 | 7.8 | Upgrade
|
| Total Debt | 0.95 | 0.96 | 0.39 | 0.79 | 0.27 | 0.32 | Upgrade
|
| Net Cash (Debt) | 2.51 | 5.65 | 8.57 | 5.43 | 7.14 | 5.53 | Upgrade
|
| Net Cash Growth | -70.15% | -34.01% | 57.80% | -23.98% | 29.08% | -69.24% | Upgrade
|
| Net Cash Per Share | 4.40 | 14.83 | 69.96 | 193.57 | 531.24 | 529.76 | Upgrade
|
| Filing Date Shares Outstanding | 1.21 | 0.67 | 0.17 | 0.05 | 0.02 | 0.01 | Upgrade
|
| Total Common Shares Outstanding | 0.72 | 0.45 | 0.17 | 0.03 | 0.02 | 0.01 | Upgrade
|
| Working Capital | 3.68 | 6.72 | 9.33 | 6.28 | 6.16 | 4.64 | Upgrade
|
| Book Value Per Share | 8.54 | 20.64 | 72.65 | 279.06 | 458.14 | 563.00 | Upgrade
|
| Tangible Book Value | 4.48 | 7.42 | 10.14 | 6.97 | 6.31 | 4.79 | Upgrade
|
| Tangible Book Value Per Share | 6.19 | 16.65 | 60.95 | 214.23 | 392.20 | 458.93 | Upgrade
|
| Machinery | 0.47 | 0.47 | 0.48 | 0.25 | 0.07 | 0.06 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.04 | 0.04 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.